CRISPR Therapeutics AG (C2RS34)
Market Closed
12 Jun, 19:55
B3 B3 Primary R$
32. 26
-0.2
-0.6161%
R$
3.73B Market Cap
- P/E Ratio
- Div Yield
20 Volume
-2.71 Eps
R$ 32.46
Previous Close Want to track C2RS34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CRISPR Therapeutics AG (C2RS34) Statistics
Valuation metrics
Market Cap 3.73B
Enterprise value 6.43B
Trailing P/E (ttm) 1.69
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 0.36
Enterprise Value/Revenue 319.21
Enterprise Value/EBITDA -2.47
Overview
Shares outstanding -
Float 96.02M
Shares short -
% Held by insiders -
% Held by institutions 0%
Average volume (10 days) 242
Average volume (90 days) 255
Price summary
52-Week low 27.98
52-Week high 52.15
Beta 1.74
50-Day moving average 34.64
200-Day moving average 36.93
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -89.33%
Operational effectiveness
Return on assets -0.14%
Return on equity -0.31%
Income Statement
Revenue (ttm) 20.13M
Revenue per share (ttm) 0.04
Quarterly revenue growth (yoy) 0.69%
Gross profit (ttm) -2.35B
EBITDA -2.61B
Net income to common (ttm) -2.79B
Diluted EPS (ttm) 20.03
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 11.98B
Total cash per share (mrq) 25.32
Total debt (mrq) 3.86B
Total Debt/Equity (mrq) 43.41
Current ratio (mrq) 17.96%
Book value per share (mrq) 93.01
Cash Flow
Cash flow statement -1.96B
Levered free cash flow (LFCF) -1.28B
